This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The impact of early-life sub-therapeutic antibiotic treatment (STAT) on excessive weight is robust despite transfer of intestinal microbes
The ISME Journal Open Access 16 January 2019
-
Modulating bacterial and gut mucosal interactions with engineered biofilm matrix proteins
Scientific Reports Open Access 22 February 2018
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
15 February 2017
In the January 2017 issue, the piece “Living therapeutics: Scientists genetically modify bacteria to deliver drugs” (Nat. Med. 23, 5–7, 2017) incorrectly stated that the company Oragenics is slated to launch a phase 2 trial on ulcerative mucositis next year. In fact, they will begin the trial in 2017. The error has been corrected in the HTML and PDF versions of this article.
References
Joint United Nations Programme on HIV/AIDS. 2004 report on the global AIDS epidemic. (4th global report) 1–236 (UNAIDS, Geneva, 2004).
Steidler, L. Antonie Van Leeuwenhoek 82, 323–331 (2002).
Steidler, L. et al. Nat. Biotechnol. 21, 785–789 (2003).
Vandenbroucke, K. et al. Mucosal Immunol. 3, 49–56 (2010).
Limaye, S.A. et al. Cancer 119, 4268–4276 (2013).
Langenaur, L.A. et al. Mucosal Immunol. 4, 648–657 (2011).
Roberts, N.J. et al. Sci. Transl. Med. 6, 249ra111 (2014).
Quintero, D., Carrafa, J., Vincent, L. & Bermudes, D. Biotechnol. Bioeng. 113, 2698–2711 (2016).
Paton, A.W., Morona, R. & Paton, J.C. et al. Nat. Rev. Microbiol. 4, 193–200 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maxmen, A. Living therapeutics: Scientists genetically modify bacteria to deliver drugs. Nat Med 23, 5–7 (2017). https://doi.org/10.1038/nm0117-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0117-5
This article is cited by
-
Bacterial therapies at the interface of synthetic biology and nanomedicine
Nature Reviews Bioengineering (2023)
-
Engineered living biomaterials
Nature Reviews Materials (2021)
-
Materials design by synthetic biology
Nature Reviews Materials (2020)
-
The impact of early-life sub-therapeutic antibiotic treatment (STAT) on excessive weight is robust despite transfer of intestinal microbes
The ISME Journal (2019)
-
Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides
Applied Microbiology and Biotechnology (2019)